🔗 Share this article

The prestigious award in medical science has been granted for transformative discoveries that illuminate how the immune system targets dangerous infections while sparing the body's own cells.

Three esteemed scientists—from Japan Prof. Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

The work identified unique "sentinels" within the defense system that remove malfunctioning immune cells that could harming the organism.

These findings are now paving the way for new therapies for immune disorders and cancer.

These winners will divide a monetary award worth 11m SEK.

Crucial Discoveries

"Their research has been essential for understanding how the immune system operates and the reason we do not all suffer from serious self-attack conditions," stated the chair of the Nobel Committee.

This trio's studies explain a fundamental mystery: In what way does the defense system protect us from countless invaders while leaving our own tissues unharmed?

Our body's protection system employs immune cells that scan for signs of infection, including viruses and germs it has never encountered.

Such defenders employ detectors—called recognition units—that are generated by chance in a vast number of variations.

This gives the immune system the capacity to combat a wide array of invaders, but the unpredictability of the mechanism unavoidably creates white blood cells that may target the host.

Protectors of the Immune System

Scientists earlier understood that some of these problematic white blood cells were destroyed in the immune organ—the site where immune cells develop.

This year's award honors the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the system to neutralize any defenders that attack the healthy cells.

It is known that this process fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel stated, "The findings have established a new field of investigation and accelerated the development of new treatments, for instance for tumors and immune disorders."

Regarding malignancies, regulatory T-cells block the body from fighting the tumor, so research are focused on lowering their numbers.

In autoimmune diseases, experiments are exploring increasing T-reg cells so the body is no longer being harmed. A similar method could also be effective in minimizing the chances of organ transplant rejection.

Pioneering Studies

Professor Sakaguchi, from Osaka University, performed tests on mice that had their immune gland removed, causing autoimmune disease.

He demonstrated that introducing defense cells from healthy mice could prevent the illness—implying there was a mechanism for preventing defenders from harming the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an inherited autoimmune disease in rodents and people that resulted in the discovery of a gene vital for the way regulatory T-cells function.

"Their groundbreaking work has uncovered how the body's defenses is kept in check by T-reg cells, preventing it from accidentally attacking the healthy cells," commented a prominent physiology specialist.

"The research is a remarkable example of how fundamental physiological research can have broad consequences for public health."